Financial Performance - Total revenue for the three months ended March 31, 2024, was 1,367,000,comparedto0 for the same period in 2023[11] - Operating expenses increased to 4,172,000forQ12024,upfrom3,834,000 in Q1 2023, representing a 9% increase[11] - Net loss for the three months ended March 31, 2024, was 5,441,000,comparedtoanetlossof3,762,000 in Q1 2023, indicating a 44.7% increase in losses[11] - The company recorded a net rent expense of 200,000forthethreemonthsendedMarch31,2024,comparedto164,000 for the same period in 2023, indicating an increase of approximately 21.9%[55] - The company incurred a loss from operations of approximately 2.8millionforthethreemonthsendedMarch31,2024,comparedtoalossof3.8 million for the same period in 2023, indicating a 1.0milliondecreaseinnetoperatingloss[85]−OtherexpensesforthethreemonthsendedMarch31,2024,wereapproximately(2.6) million, primarily due to volatility in investment valuations[85] Cash and Assets - Cash and cash equivalents decreased to 1,956,000asofMarch31,2024,downfrom2,833,000 at the end of 2023, a decline of 30.8%[9] - Total assets decreased to 52,194,000asofMarch31,2024,from57,558,000 at the end of 2023, a reduction of 9.4%[9] - Stockholders' equity decreased to 47,669,000asofMarch31,2024,downfrom52,923,000 at the end of 2023, a decline of 10%[9] - As of March 31, 2024, the Company held approximately 14.1millionindepositswithitsclearingbroker[27]−AsofMarch31,2024,thecompany′sworkingcapitalamountedtoapproximately23.8 million, which is expected to be sufficient to meet its working capital and capital expenditure requirements for at least the next 12 months[87] Investments - The company reported a change in fair value of long-term equity investments resulting in a loss of 2,459,000forQ12024[11]−TheCompany’slong−termequityinvestmentstotaled20.9 million as of March 31, 2024, down from 24.2millionasofDecember31,2023[36]−TheinvestmentinUnusualMachines,whichwentpubliconFebruary14,2024,wasvaluedbasedonitsmarketpriceasofMarch31,2024[39]−TheCompanyrecognizedrevenueunderASC606,withvariousrevenuestreamsincludingunderwritingservices,commissions,andaccountadvisoryfees[29]−TheunrealizedgainontheConvergentConvertibleNoteforthethreemonthsendedMarch31,2024,wasapproximately60,000[42] - The company reported a gain of approximately 0.6milliononmarketablesecuritiesforthethreemonthsendedMarch31,2024,drivenbymarketimprovementandincreasedsaleactivity[86]ShareholderInformation−Theweightedaveragenumberofsharesoutstandingincreasedto5,995,065forQ12024,comparedto5,305,513forQ12023,reflectinga130.2 million in unrecognized stock-based compensation expense related to restricted stock awards as of March 31, 2024[61] - The company has 444,796 warrants outstanding as of March 31, 2024, with a weighted average exercise price of 29.25andaremainingcontractuallifeof1.95years[59]LegalandCompliance−Thecompanyiscurrentlyinvolvedinalegalproceedingrelatedtothehiringofnewregisteredrepresentatives,butitcannotpredicttheoutcomeorestimateanypotentialloss[65]−Amaterialweaknesswasidentifiedintheaccountingforcertainnotesreceivableandlong−terminvestments,leadingtoincorrectinitialaccounting[95]−Managementplanstoenhancecontrolsbyconsultingexperiencedthird−partyprofessionalstoremediatetheidentifiedmaterialweakness[95]−Thecompany′sdisclosurecontrolsandprocedureswerefoundtobeineffectiveduetoamaterialweaknessininternalcontrols[93]−Thecompanyisinvolvedinlegalproceedingsrelatedtothehiringofnewregisteredrepresentatives,withpotentialexposurethatcannotbereasonablyestimated[101]StrategicInitiatives−DominariFinancialacquiredDominariSecuritiesLLCforatotalof3.4 million, enhancing its position in the financial services sector[20] - Dominari Financial seeks partnership opportunities and acquisitions of third-party financial assets to execute its growth strategy in the financial services industry[78] - The company is winding down its historical pipeline of biotechnology assets held by Aikido Labs, LLC, which includes patented technology for various treatments[79] Cash Flow - Net cash used in operations for the three months ended March 31, 2024, was approximately 8.6million,primarilyduetoanetlossofapproximately5.4 million[89] - Net cash provided by investing activities for the three months ended March 31, 2024, was approximately 7.7million,resultingfromsalesofmarketablesecurities[90]−ThecompanyhadnocashflowsfromfinancingactivitiesforthethreemonthsendedMarch31,2024,comparedtoapproximately0.9 million used in financing activities for the same period in 2023[91]